TB control study for high-risk groups in Guangxi
Part of Infections clinical trials.
This study tests new ways to control the spread of tuberculosis (TB) in high-risk areas of Guangxi, China. It focuses on older adults and people with conditions that make them more likely to get TB.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years old or older
- OR you are between 15 and 64 and have one of these: history of TB treatment, close contact with a TB patient in the last 3 years, diabetes, HIV positive, or worked as a miner
- You live in a high-prevalence area for TB in Guangxi, China
- You agree to sign a consent form
- You are not refusing to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common tuberculosis (TB) is in pregnant and new mothers in Guinea-Bissau. If you join, you'll help researchers understand the TB burden in your community, which may lead to better care for mothers and babies.
This study looks at how to best manage latent tuberculosis (TB) infection using a test that finds people at risk. It aims to help doctors and patients make better decisions together.
This trial is testing a new way to find and treat tuberculosis (TB) in communities in Ethiopia. It aims to help people of any age who live in certain areas get better care.
This study looks for TB bacteria in the blood of people with active tuberculosis and their close contacts at home. It aims to find better ways to detect TB early and prevent its spread.
This trial is testing a new way to find TB in communities, using chest X-rays that are read by a computer program to spot possible TB. If you join, you'll help see if this method works better for finding TB early.
This study tests a new tuberculosis (TB) vaccine (ID93+GLA-SE) in healthy adults aged 55 to 74. It aims to see if the vaccine is safe and can help protect against TB, especially in people who may have latent (inactive) TB infection.
Hear when a new Tuberculosis (TB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.